Effects of guided imagery on anxiety, muscle pain and vial signs in patients with COVID-19

Effects of guided imagery on anxiety, muscle pain and vial signs in patients with COVID-19 hospitalized in Taleghani Hospital and temporary housing in Urmia, 2020

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20131112015390N5

Enrollment

110

Registered

2020-09-26

Start date

2020-05-21

Completion date

Unknown

Last updated

2020-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19. COVID-19, virus identified

Interventions

Intervention 1: Intervention group: In the intervention group, a guided mental imaging protocol will be performed under the supervision of a psychiatrist. In the intervention group, in parallel with r

It will be performed once in the morning from 9:00 to 9:30 and once in the evening from 18:00 to 18:30 in the patient's room. During each session, the patient listens for about 25 minutes to the headp

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: The sample should be positive for covid-19 with PCR test. Be between 18 and 60 years old. Allow the treating physician to intervene. The sample must be alert and oriented. Be able to speak Persian. Willingness to participate in the study with complete satisfaction.

Exclusion criteria

Exclusion criteria: The sample have a history of mental illness and a previous history of Covid-19. SPO2% < 93%

Design outcomes

Primary

Measure	Time frame
Anxiety Scale in Spielberger's Hidden and Obvious Anxiety Scale Questionnaire. Timepoint: Measuring anxiety in the first session (before the intervention) and then After completing the guided mental imagery training sessions on the fifth day. Method of measurement: Spielberger's Hidden and Obvious Anxiety Scale Questionnaire.;Pain Quality Score on the McGill Pain Questionnaire. Timepoint: Measuring quality of pain in the first session (before the intervention) and then After completing the guided mental imagery training sessions on the fifth day. Method of measurement: McGill Pain Questionnaire.;Pain intensity score on the Visual Analog Scale. Timepoint: Measuring pain intensity in the first session (before the intervention) and then After completing the guided mental imagery training sessions on the fifth day. Method of measurement: Visual Analog Scale.	—

Measure

Time frame

Anxiety Scale in Spielberger's Hidden and Obvious Anxiety Scale Questionnaire. Timepoint: Measuring anxiety in the first session (before the intervention) and then After completing the guided mental imagery training sessions on the fifth day. Method of measurement: Spielberger's Hidden and Obvious Anxiety Scale Questionnaire.;Pain Quality Score on the McGill Pain Questionnaire. Timepoint: Measuring quality of pain in the first session (before the intervention) and then After completing the guided mental imagery training sessions on the fifth day. Method of measurement: McGill Pain Questionnaire.;Pain intensity score on the Visual Analog Scale. Timepoint: Measuring pain intensity in the first session (before the intervention) and then After completing the guided mental imagery training sessions on the fifth day. Method of measurement: Visual Analog Scale.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNaser Parizad

Oroumia University of Medical Sciences

parizad.n@umsu.ac.ir+98 44 1348 7649

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 6, 2026